Vardan T. Karamyan

2.3k total citations · 1 hit paper
72 papers, 1.7k citations indexed

About

Vardan T. Karamyan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vardan T. Karamyan has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vardan T. Karamyan's work include Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (18 papers) and Renin-Angiotensin System Studies (17 papers). Vardan T. Karamyan is often cited by papers focused on Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (18 papers) and Renin-Angiotensin System Studies (17 papers). Vardan T. Karamyan collaborates with scholars based in United States, Armenia and Saudi Arabia. Vardan T. Karamyan's co-authors include Robert C. Speth, Abdullah Al Shoyaib, Sabrina Rahman Archie, Thomas J. Abbruscato, Thiruma V. Arumugam, Yang Li, Faisal F. Alamri, Kaushik Shah, Hezhen Wang and Mamoon Ur Rashid and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Vardan T. Karamyan

69 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?

2019 387 citations Abdullah Al Shoyaib, Sabrina Rahman Archie et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vardan T. Karamyan United States	23	725	397	273	231	215	72	1.7k
Nobuo Katsube Japan	25	1.1k 1.5×	411 1.0×	349 1.3×	210 0.9×	341 1.6×	53	2.3k
Marta Tajes Spain	25	585 0.8×	288 0.7×	150 0.5×	198 0.9×	520 2.4×	45	1.7k
Xiaobo Cen China	28	1.4k 1.9×	410 1.0×	127 0.5×	96 0.4×	272 1.3×	102	2.7k
Gyung Whan Kim South Korea	27	1.2k 1.6×	460 1.2×	161 0.6×	523 2.3×	405 1.9×	62	2.5k
Subir Roy Chowdhury Canada	25	944 1.3×	258 0.6×	157 0.6×	109 0.5×	815 3.8×	53	1.9k
M. Bastide France	21	820 1.1×	265 0.7×	99 0.4×	328 1.4×	239 1.1×	57	1.9k
Kun Zou Japan	26	1.2k 1.6×	386 1.0×	170 0.6×	339 1.5×	1.2k 5.5×	75	2.7k
Soo‐Hwan Lee South Korea	29	1.1k 1.5×	428 1.1×	72 0.3×	317 1.4×	445 2.1×	77	2.6k
Carla Perego Italy	30	1.2k 1.6×	552 1.4×	96 0.4×	129 0.6×	358 1.7×	73	2.9k
Andrzej Szutowicz Poland	28	1.0k 1.4×	603 1.5×	107 0.4×	190 0.8×	734 3.4×	124	2.6k

Countries citing papers authored by Vardan T. Karamyan

Since Specialization

Citations

This map shows the geographic impact of Vardan T. Karamyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vardan T. Karamyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vardan T. Karamyan more than expected).

Fields of papers citing papers by Vardan T. Karamyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vardan T. Karamyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vardan T. Karamyan. The network helps show where Vardan T. Karamyan may publish in the future.

Co-authorship network of co-authors of Vardan T. Karamyan

This figure shows the co-authorship network connecting the top 25 collaborators of Vardan T. Karamyan. A scholar is included among the top collaborators of Vardan T. Karamyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vardan T. Karamyan. Vardan T. Karamyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alamri, Faisal F., et al.. (2025). Assessing the effects of antidepressant use on stroke recurrence and related outcomes in ischemic stroke patients: a propensity score matched analysis. Frontiers in Pharmacology. 16. 1558703–1558703.

Zhang, Yong, Dhaval Patel, Sounak Bagchi, et al.. (2024). Evaluation of systemic and brain pharmacokinetic parameters for repurposing metformin using intravenous bolus administration. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100013–100013. 7 indexed citations

Bagchi, Sounak, et al.. (2024). Structural basis of divergent substrate recognition and inhibition of human neurolysin. Scientific Reports. 14(1). 18420–18420. 1 indexed citations

Alamri, Faisal F., et al.. (2023). A Low-Budget Photothrombotic Rodent Stroke Model. Methods in molecular biology. 21–28. 1 indexed citations

Bagchi, Sounak, et al.. (2023). Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration. Pharmaceutics. 16(1). 53–53. 3 indexed citations

Candelario‐Jalil, Eduardo, et al.. (2022). Translating Animal Models of Ischemic Stroke to the Human Condition. Translational Stroke Research. 14(6). 842–853. 8 indexed citations

Karamyan, Vardan T., et al.. (2022). Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications. Journal of Pharmacology and Experimental Therapeutics. 383(2). 149–156. 3 indexed citations

Al‐Ahmad, Abraham, et al.. (2021). Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model. Journal of Neuroendocrinology. 33(2). e12931–e12931. 19 indexed citations

Karamyan, Vardan T.. (2019). Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders. Medical Hypotheses. 131. 109309–109309. 12 indexed citations

10.

Sifat, Ali Ehsan, Saeideh Nozohouri, Heidi Villalba, et al.. (2019). Prenatal electronic cigarette exposure decreases brain glucose utilization and worsens outcome in offspring hypoxic–ischemic brain injury. Journal of Neurochemistry. 153(1). 63–79. 28 indexed citations

11.

Shoyaib, Abdullah Al, Sabrina Rahman Archie, & Vardan T. Karamyan. (2019). Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?. Pharmaceutical Research. 37(1). 12–12. 387 indexed citations breakdown →

12.

Thekkumkara, Thomas, et al.. (2015). Competitive Binding Assay for the G-Protein-Coupled Receptor 30 (GPR30) or G-Protein-Coupled Estrogen Receptor (GPER). Methods in molecular biology. 1366. 11–17. 5 indexed citations

13.

Karamyan, Vardan T., et al.. (2011). TANNIC ACID AN INHIBITOR FOR ANGIOTENSIN TYPE 1 RECEPTOR AND HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS. The FASEB Journal. 25(S1). 4 indexed citations

14.

Karamyan, Vardan T., et al.. (2011). Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes. Patient Related Outcome Measures. 2. 27–27. 8 indexed citations

15.

Li, Yang, Kaushik Shah, Hezhen Wang, Vardan T. Karamyan, & Thomas J. Abbruscato. (2011). Characterization of Neuroprotective Effects of Biphalin, an Opioid Receptor Agonist, in a Model of Focal Brain Ischemia. Journal of Pharmacology and Experimental Therapeutics. 339(2). 499–508. 38 indexed citations

16.

Rashid, Mamoon Ur, Thiruma V. Arumugam, & Vardan T. Karamyan. (2010). Association of the Novel Non-AT1, Non-AT2 Angiotensin Binding Site with Neuronal Cell Death. Journal of Pharmacology and Experimental Therapeutics. 335(3). 754–761. 20 indexed citations

17.

Thundyil, John, Sung‐Chun Tang, Eitan Okun, et al.. (2010). Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. PubMed. 2(1). 15–15. 44 indexed citations

18.

Lathia, Justin D., Srinivasulu Chigurupati, John Thundyil, et al.. (2009). Pivotal role for beta-1 integrin in neurovascular remodelling after ischemic stroke. Experimental Neurology. 221(1). 107–114. 25 indexed citations

19.

Karamyan, Vardan T., Craig A. Stockmeier, & Robert C. Speth. (2008). Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides. Life Sciences. 83(11-12). 421–425. 15 indexed citations

20.

Karamyan, Vardan T. & Robert C. Speth. (2007). Enzymatic pathways of the brain renin–angiotensin system: Unsolved problems and continuing challenges. Regulatory Peptides. 143(1-3). 15–27. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact